GLP1 (1-37), human TFA
|
G659328-500μg
|
≥98% |
N/A |
500μg
|
¥ 2970.9
|
期货,请咨询 |
阿拉丁 |
GLP1 (1-37), human TFA
|
G659328-1mg
|
≥98% |
N/A |
1mg
|
¥ 4840.9
|
期货,请咨询 |
阿拉丁 |
GalNAc unconjugated/naked Fitusiran
|
G659320-1mg
|
|
N/A |
1mg
|
¥ 11800.9
|
期货,请咨询 |
阿拉丁 |
Galantide TFA
|
G659296-5mg
|
≥98% |
N/A |
5mg
|
¥ 7200.9
|
期货,请咨询 |
阿拉丁 |
Galantide TFA
|
G659296-500μg
|
≥98% |
N/A |
500μg
|
¥ 1400.9
|
期货,请咨询 |
阿拉丁 |
Galantide TFA
|
G659296-1mg
|
≥98% |
N/A |
1mg
|
¥ 2400.9
|
期货,请咨询 |
阿拉丁 |
Glycyl-Exatecan-d5hydrochloride
|
G659275-1mg
|
≥95% |
N/A |
1mg
|
¥ 18500.9
|
期货,请咨询 |
阿拉丁 |
Gap19 TFA
|
G659263-5mg
|
≥99% |
N/A |
5mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
Gap19 TFA
|
G659263-1mg
|
≥99% |
N/A |
1mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
Gap19 TFA
|
G659263-10mg
|
≥99% |
N/A |
10mg
|
¥ 7500.9
|
期货,请咨询 |
阿拉丁 |
Gln-AMS TFA
|
G659261-5mg
|
≥98% |
N/A |
5mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
Gln-AMS TFA
|
G659261-50mg
|
≥98% |
N/A |
50mg
|
¥ 27500.9
|
期货,请咨询 |
阿拉丁 |
Gln-AMS TFA
|
G659261-25mg
|
≥98% |
N/A |
25mg
|
¥ 17500.9
|
期货,请咨询 |
阿拉丁 |
Gln-AMS TFA
|
G659261-10mg
|
≥98% |
N/A |
10mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
Gln-AMS TFA
|
G659261-100mg
|
≥98% |
N/A |
100mg
|
¥ 39500.9
|
期货,请咨询 |
阿拉丁 |
Golotimod hydrochloride
|
G659236-5mg
|
≥99% |
N/A |
5mg
|
¥ 650.9
|
期货,请咨询 |
阿拉丁 |
Golotimod hydrochloride
|
G659236-50mg
|
≥99% |
N/A |
50mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
Golotimod hydrochloride
|
G659236-10mg
|
≥99% |
N/A |
10mg
|
¥ 1000.9
|
期货,请咨询 |
阿拉丁 |
Golotimod hydrochloride
|
G659236-100mg
|
≥99% |
N/A |
100mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
|
G659225-5mg
|
≥99% |
N/A |
5mg
|
¥ 9800.9
|
期货,请咨询 |
阿拉丁 |
GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
|
G659225-1mg
|
≥99% |
N/A |
1mg
|
¥ 2800.9
|
期货,请咨询 |
阿拉丁 |
GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
|
G659225-10mg
|
≥99% |
N/A |
10mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
GSK-J1 lithium salt
|
G659223-50mg
|
|
N/A |
50mg
|
¥ 2050.9
|
期货,请咨询 |
阿拉丁 |
GSK-J1 lithium salt
|
G659223-25mg
|
|
N/A |
25mg
|
¥ 1150.9
|
期货,请咨询 |
阿拉丁 |